Inpart
Created in 2010
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
339 412 10,657Activities
Technologies
Entity types
Location
89 Rue Tronchet, 69006 Lyon, France
Lyon
France
Employees
Scale: 51-200
Estimated: 200
SIREN
434448866Engaged corporates
29
3 23Added in Motherbase
5 years, 7 months ago
biotech Value proposition
An online platform for scientific partnering helping take discoveries from bench to bedside.
Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia.
In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry.
The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations.
Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.
Partnering Platform, Business Development Database, Pharma Due Diligence, Biopharma Business Development, Biopharma Partnering, Biopharma Database, Biotech Business Development, Biopharma CRM, Partner Relationship Management, Partnering Project Management, Business Development Software, Alliance Management, Partnering Conferences, Digital Partnering, Business Process Management, Lead Generation, Lead Management, Search & Evaluation, Dealflow Reporting, Biotech Business Planning, Pharma Business Planning, External Innovation Management, Technology transfer, Open innovation, Research Commercialisation, and Research CommercializationOriginal language
An online platform for scientific partnering helping take discoveries from bench to bedside.
Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia.
In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry.
The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations.
Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.
End-to-end platform for science partnering • Inpart
Your trusted partner for science partnering, providing solutions to facilitate, optimize and track interactions in the biopharma, scientific and academic sectors.
https://www.inpart.io/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 29 Oct 2024 | | |
 Asahi Kasei Chemistry | Asahi Kasei Chemistry | Other 15 Feb 2024 | | |
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 16 Dec 2023 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Dec 2023 | | |
 Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 27 Jul 2023 | | |
 La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | La French Tech Saint-Etienne Lyon French Tech, IT Services and IT Consulting | Other 5 Jul 2023 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 20 Mar 2023 17 Apr 2023 | | |
 STMicroelectronics Semiconductors, Semiconductor Manufacturing | STMicroelectronics Semiconductors, Semiconductor Manufacturing | Other 5 Mar 2022 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 20 Mar 2023 16 Dec 2023 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 1 Mar 2018 | | |